Information for healthcare professionals
AASLD=American Association for the Study of Liver Diseases; ACP=American College of Physicians; CDC=Centers for Disease Control and Prevention; USPSTF=U.S. Preventive Services Task Force.
References:
- Gish R, Cohen C, Block J, et al. Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States. Hepatology. 2015;62:1339-1341. doi:10.1002/hep.28026
- Kowdley K, Wang C, Welch S, et al. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012;56:422-433. doi:10.1002/hep.24804
- U.S. Census Bureau. U.S. and World Population Clock. Accessed October 1, 2019. https://www.census.gov/popclock/
- Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599. doi:10.1002/hep.29800
- Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States?J Viral Hepat. 2011;18:377-383. doi:10.1111/j.1365-2893.2010.01401.x
- World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva, Switzerland: World Health Organization; 2015.
- Abara W, Qaseem A, Schillie S, et al. Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017;167(11):794-804. doi:10.7326/M17-1106